Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azor vs Hyzaar in African Americans with Cardiometabolic Syndrome
NCT01271374Phase 4Unknown
- Sponsor
- InVasc Therapeutics, Inc.
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan medoxomil + amlodipine in hypertension (HTN), metabolic syndrome, sponsored by InVasc Therapeutics, Inc.. Status: unknown.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
hypertension (HTN)metabolic syndrome
Beyond the preview
Go deeper on NCT01271374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271374.